OPEN Health to increase focus in cancer

Written on Friday 5th September 2014

Cancer treatments are seen as one of the major growth drivers of the pharmaceutical industry, and several of the companies in the OPEN Health Group have significant experience in the area; in particular Succinct Medical Communications has built a very strong oncology practice and are seen by many as the premier cancer communications agency in Europe.

In order to harness this cross group expertise, OPEN Health has appointed Sean McGrath (pictured) as Director of Oncology across the whole OPEN Health Group. Sean will also continue in his role as Chairman of Succinct. Sean’s principal focus will be to connect the wider group expertise to enhance the marketing and communications of our client’s oncology brands. Sean has personally worked in oncology for over 20 years, and has expertise across all tumour sites and classes of drugs.

‘Oncology continues to be a driver for success in many pharma companies and it’s only natural that we continue to adapt and build in order to meet this on-going demand across all of OPEN’s offerings. We take oncology seriously here at OPEN and I am excited to be leading this initiative’ said McGrath.

OPEN, who acquired Succinct a few years ago, has over 20 oncology companies as clients including all the recognised market leaders. David Rowley, OPEN’s CEO commented: ‘We are delighted to be able to spread Succinct’s obvious and acknowledged expertise across the OPEN Group. Our clients are aware of this expertise and are keen to utilise it whenever possible. With more and more companies entering into the oncology arena, it is essential they understand the nuances, opportunities and pitfalls involved in the cancer space. Sean’s Director of Oncology role is also a reflection of how committed we are to cancer and our oncology clients’.

OPEN Health is a healthcare communications and market access group. It is made up of specialist, best-in-class businesses, that individually are experts in their own fields. Currently, we are a group of around 200 people, operating across a wide range of disciplines. We work with almost all of the world’s top 40 pharmaceutical companies, as well as with many device, diagnostic and healthcare delivery organisations, from small start-ups to major multinationals at a UK, regional and global level.

Sean McGrath:  +44 7768 414499
David Rowley:  +44 7973 669689